Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A choriocarcinoma arising from the ovary. When it appears before puberty is of germ cell origin. In children and young adults signs and symptoms include precocious pseudopuberty and vaginal bleeding. Serum human chorionic gonadotropin is elevated. Germ cell derived ovarian choriocarcinoma should be differentiated from primary or metastatic gestational choriocarcinoma affecting the ovary. The prognosis of germ cell derived choriocarcinoma is less favorable and requires more aggressive chemotherapy treatment regimens compared to gestational choriocarcinoma.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
11 publications have been identified in PubMed for choriocarcinoma of ovary. Research spans Case Report / Case Series (70%), Review / Meta-Analysis (10%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:42 PM UTC
70%
Research summaries | 1 | 10% |
Laboratory research | 1 | 10% |
Disease patterns and progression | 1 | 10% |
Kuai Y (2026). [PMID: 42072692](https://pubmed.ncbi.nlm.nih.gov/42072692/). *Biomolecules*. [Review / Meta-Analysis]
Zanfagnin V (2026). [PMID: 41887253](https://pubmed.ncbi.nlm.nih.gov/41887253/). *Arch Pathol Lab Med*. [Basic Science / Preclinical]
Ordoñez Arrillaga A (2026). [PMID: 41579581](https://pubmed.ncbi.nlm.nih.gov/41579581/). *Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia*. [Case Report / Case Series]
Masaadeh AH (2025). [PMID: 39475366](https://pubmed.ncbi.nlm.nih.gov/39475366/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Case Report / Case Series]
Selamioglu A (2025). [PMID: 41597044](https://pubmed.ncbi.nlm.nih.gov/41597044/). *Children (Basel, Switzerland)*. [Case Report / Case Series]
Youssef AT (2025). [PMID: 38409507](https://pubmed.ncbi.nlm.nih.gov/38409507/). *Journal of ultrasound*. [Case Report / Case Series]
Kara SS (2025). [PMID: 39090978](https://pubmed.ncbi.nlm.nih.gov/39090978/). *International journal of surgical pathology*. [Case Report / Case Series]
Ao X (2024). [PMID: 38701311](https://pubmed.ncbi.nlm.nih.gov/38701311/). *Medicine*. [Case Report / Case Series]
Sait HK (2024). [PMID: 39246853](https://pubmed.ncbi.nlm.nih.gov/39246853/). *Cureus*. [Case Report / Case Series]
Gafar I (2024). [PMID: 39712678](https://pubmed.ncbi.nlm.nih.gov/39712678/). *Cureus*. [Epidemiology / Natural History]